202 related articles for article (PubMed ID: 30503967)
41. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
[TBL] [Abstract][Full Text] [Related]
42. Improving fecal occult blood testing compliance using a mailed educational reminder.
Lee JK; Reis V; Liu S; Conn L; Groessl EJ; Ganiats TG; Ho SB
J Gen Intern Med; 2009 Nov; 24(11):1192-7. PubMed ID: 19774423
[TBL] [Abstract][Full Text] [Related]
43. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
[TBL] [Abstract][Full Text] [Related]
44. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
[TBL] [Abstract][Full Text] [Related]
45. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
[TBL] [Abstract][Full Text] [Related]
46. Application of Behavioral Economics Principles Improves Participation in Mailed Outreach for Colorectal Cancer Screening.
Bakr O; Afsar-Manesh N; Raja N; Dermenchyan A; Goldstein NJ; Shu SB; May FP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00115. PubMed ID: 31972609
[TBL] [Abstract][Full Text] [Related]
47. Outreach and Inreach Strategies for Colorectal Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015-2018.
Castañeda SF; Bharti B; Rojas M; Mercado S; Bearse AM; Camacho J; Lopez MS; Muñoz F; O'Connell S; Liu L; Talavera GA; Gupta S
Am J Public Health; 2020 Apr; 110(4):587-594. PubMed ID: 32078353
[No Abstract] [Full Text] [Related]
48. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2017 Nov; 86(5):892-899. PubMed ID: 28385585
[TBL] [Abstract][Full Text] [Related]
49. Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting.
Castañeda SF; Bharti B; Espinoza-Giacinto RA; Sanchez V; O'Connell S; Muñoz F; Mercado S; Meza ME; Rojas W; Talavera GA; Gupta S
J Racial Ethn Health Disparities; 2018 Jun; 5(3):530-535. PubMed ID: 28634873
[TBL] [Abstract][Full Text] [Related]
50. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
[TBL] [Abstract][Full Text] [Related]
51. Get screened: a randomized trial of the incremental benefits of reminders, recall, and outreach on cancer screening.
Fortuna RJ; Idris A; Winters P; Humiston SG; Scofield S; Hendren S; Ford P; Li SX; Fiscella K
J Gen Intern Med; 2014 Jan; 29(1):90-7. PubMed ID: 24002626
[TBL] [Abstract][Full Text] [Related]
52. Change to FIT increased CRC screening rates: evaluation of a US screening outreach program.
Liles EG; Perrin N; Rosales AG; Feldstein AC; Smith DH; Mosen DM; Schneider JL
Am J Manag Care; 2012 Oct; 18(10):588-95. PubMed ID: 23145804
[TBL] [Abstract][Full Text] [Related]
53. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
54. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
55. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
[TBL] [Abstract][Full Text] [Related]
56. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial.
Christy SM; Sutton SK; Abdulla R; Boxtha C; Gonzalez P; Cousin L; Ewing A; Montoya S; Lopez D; Beehler T; Sanchez J; Carvajal R; Meade CD; Gwede CK
Prev Med; 2022 May; 158():107021. PubMed ID: 35305995
[TBL] [Abstract][Full Text] [Related]
57. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
[TBL] [Abstract][Full Text] [Related]
58. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.
Gies A; Cuk K; Schrotz-King P; Brenner H
Clin Transl Gastroenterol; 2018 Jul; 9(7):168. PubMed ID: 29976921
[TBL] [Abstract][Full Text] [Related]
59. Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
Grazzini G; Ventura L; Rubeca T; Rapi S; Cellai F; Di Dia PP; Mallardi B; Mantellini P; Zappa M; Castiglione G
Eur J Cancer Prev; 2017 Jul; 26(4):285-291. PubMed ID: 27271031
[TBL] [Abstract][Full Text] [Related]
60. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
